Surgical Robotics Technology
Quantum Surgical has announced that The Léon Bérard Center (CLB) has just installed Epione®, the platform developed by Quantum Surgical that enables early and curative treatment of tumors. The first patients have already been treated. CLB becomes the sixth site in France to offer this minimally invasive treatment, which destroys abdominal and lung tumors by inserting a needle through the skin.
Specializing in robotics and artificial intelligence, Quantum Surgical develops the Epione robotic platform, which enables physicians to perform safe and effective percutaneous tumor ablations. This minimally invasive treatment is an alternative to surgery, involving the insertion of one or more needles through the skin to reach and destroy the tumor.
Epione has already been used to treat 875 patients worldwide and is now available at Léon Bérard Center in Lyon.
“The adoption of the Epione robot marks a major advancement for our department and our patients. Thanks to this cutting-edge technology, we can perform minimally invasive procedures with unmatched precision, thereby reducing risks and significantly improving patient care. This innovation strengthens our commitment to providing the highest quality of care in interventional radiology,” explains Dr. Amine Bouhamama, interventional radiologist at the Léon Bérard Center.
“At the Léon Bérard Center, we are deeply committed to offering our patients ever more advanced and compassionate care. We are therefore proud to integrate the innovation represented by Epione into our therapeutic options, providing our patients with procedures that are more precise, less invasive, and safer,” says Professor Jean-Yves Blay, General Director of the Léon Bérard Center.
“We are delighted with this new installation at the Léon Bérard Center. The deployment of a second Epione just weeks after the one at Toulouse University Hospital is a true validation of the benefits our platform offers. The entire Quantum Surgical team is thrilled that more patients can now benefit from our technology to treat their tumors,” says Bertin Nahum, President and Co-founder of Quantum Surgical.
Epione is CE-marked in Europe for abdominal and lung tumors and FDA-approved in the United States for abdominal tumors. Epione is available in about 20 hospitals worldwide including at Baptist Health South Florida in Miami, Florida and Rush University System Health in Chicago, Illinois.
Source: Quantum Surgical
